Patients with NAFLD had significantly lower HMW adiponectin levels than controls (4.2±0.7 vs. 5.0±0.5 μg/ml, p< 0.001). This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.